In a recent controversy, it has been revealed that President Lee Myung-bak’s former secretary-in-law, who holds a patent for a medicinal herb, has sparked suspicions of favoritism as the herb was recognized in the health insurance pilot program. According to Kang Seon-woo, a Democratic Party lawmaker, Shin Jun-sik, the director of Jasaeng Oriental Medicine Hospital and the secretary-in-law, obtained a patent for ‘Harpgophyteumguen’ (Cheonsu root), which was recognized as a pilot herbal medicine on March 12th. However, during the pilot program from April to August, only 21 Jasaeng-affiliated traditional Korean medicine hospitals and clinics claimed 99.6% of total reimbursements amounting to 3.77 billion won. This disproportionate distribution has raised concerns about undue favoritism in the process.
While Jasaeng Oriental Medicine Hospital defended the selection of Harpgophyteumguen, claiming its effectiveness in treating back pain, the lawmaker called for a closer examination of the relationship between the hospital and the presidential office. The lawmaker emphasized the need to address any suspicions of favoritism in order to ensure fair access to traditional Korean medicine for the public. For further inquiries, contact Reporter Seo Young-ji at yj@hani.co.kr.
Source link